Craniofacial growth in short children born small for gestational age: Effect of growth hormone treatment

Journal of Dental Research

Volumn 76, Issue 9, 1997, Pages 1579-1586

  Van Erum, R ^a   Mulier, M ^a   Cards, C ^b   Verbeke, G ^b   De Zegher, F ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Cephalometry; Intra uterine growth retardation; Longitudinal study

Indexed keywords

GROWTH PROMOTOR;

AGE; AGE DETERMINATION; ARTICLE; BODY HEIGHT; CEPHALOMETRY; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EVALUATION; FEMALE; FOLLOW UP; GROWTH DISORDER; GROWTH, DEVELOPMENT AND AGING; HUMAN; MALE; MANDIBLE; MAXILLA; MAXILLOFACIAL DEVELOPMENT; MULTICENTER STUDY; NEWBORN; NOSE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RETROGNATHIA; SKULL BASE; SMALL FOR DATE INFANT; SUBCUTANEOUS DRUG ADMINISTRATION; TOOTH OCCLUSION;

AGE DETERMINATION BY SKELETON; AGE FACTORS; BODY HEIGHT; CEPHALOMETRY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EVALUATION STUDIES; FEMALE; FOLLOW-UP STUDIES; GROWTH DISORDERS; GROWTH SUBSTANCES; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INJECTIONS, SUBCUTANEOUS; MALE; MANDIBLE; MAXILLA; MAXILLOFACIAL DEVELOPMENT; NOSE; RETROGNATHISM; SKULL BASE; VERTICAL DIMENSION;

EID: 0031226380     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/00220345970760091001     Document Type: Article

References (31)

1. Albertsson-Wikland K (1989). Growth hormone secretion and growth hormone treatment in children with intrauterine growth retardation. ActaPaediatr Scand 349(Suppl):35-41.
2. Baughan B, Demirjian A, Levesque GY, La Palme-Chaput L (1979). The pattern of facial growth before and during puberty, as shown by French-Canadian girls. Ann Hum Biol 6:59-76.
3. Bjork A, Helm S (1967). Prediction of the age of maximum pubertal growth in body height. Angle Ortliod 37:134-143.
4. Broadbent BH Sr, Broadbent BH Jr, Golden WH (1975). Bolton standards of dentofacial developmental growth. St. Louis, MO: The C.V. Mosby Company.
5. Buschang PH, Baume RM, Nass GG (1983). A craniofacial growth maturity gradient for males and females between 4 and 16 years of age. Am J Phys Anthnpol 61:373-381.
6. Châtelain P, Job JC, Blanchard J, Ducret JP, Oliver M, Sagnard L, et al. (1994). Dose-dependent catch-up growth after 2 years of growth hormone treatment in intrauterine growth-retarded children. J Clin Endocrinol Metab 78:1454-1460.
7. de Zegher F, Kimpen J, Raus J, VanderschuerenLodeweyckx M (1990). Hypersomatotropism in the dysmature infant at term and preterm birth. Biol Neonate 58:188-191.
8. de Zegher F, Maes M, Gargosky SE, Heinrichs C, Du Caju MV, Thiry G, et al. (1996a). High-dose growth hormone treatment of short children born small for gestational age. J Clin Endocrinol Melab 81:1887-1892.
9. de Zegher F, Albertsson-Wikland K, Wilton P, Châtelain P, Jonsson B, Löfström A, et al. (1996b). Growth hormone treatment of short children born small for gestational age: metanalysis of four randomized, controlled, multicentre studies. Acta Paediatr Scand 417(Suppl):27-31.
10. Fitzhardinge PM, Inwood S (1989). Long-term growth in small-for-date children. Acta Paediatr Scand 349 (Suppl):27-33.
11. Foley TP Jr, Thompson RG, Shaw M, Baghdassarian A, Nissley SP, Blizzard RM (1974). Growth responses to human growth hormone in patients with intrauterine growth retardation. J Pediatr 84:635-641.
12. Giudice LC, de Zegher F, Gargosky SE, Dsupin BA, de las Fuentes L, Crystal RA, et al. (1995). Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 80:1548-1555.
13. Grunt JA, Enriquez AR, Daughaday WH (1972). Acute and long-term responses to hGH in children with idiopathic small-for-dates dwarfism. J Clin Endocrinol Metab 35:157-168.
14. Heinrich UE (1992). Intrauterine growth retardation and familial short stature. Baillière's Clin Endocrinol Metab 6:589-601.
15. Hokken-Koelega AC, De Ridder MA, Lemmen RJ, Den Hartog H, De Muinck, Keizer-Schrama SM, et al. (1995). Children born small for gestational age: do they catch up? Pediatr Res 38:267-271.
16. Isaksson OG, Lindahl A, Nilsson A, Isgaard J (1987).
17. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 8:426-438.
18. Karlberg J, Albertsson-Wikland K (1995). Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res 38:733-739.
19. Lanes R, Plotnick LP, Lee PA (1979). Sustained effect of human growth hormone therapy on children with intrauterine growth retardation. Pediatrics 63:731-735.
20. Lassarre C, Hardouin S, Daffos F, Forestier F, Frankenne F, Binoux M (1991). Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus: relationships \vith growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res 29:219-225.
21. Nanda RS (1955). The rates of growth of several facial components measured from serial cephalometric Roentgenograms. Am J Orthod 41:653-673.
22. Ohtsuki F, Mukherjee D, Lewis AB, Roche AF (1982). Growth of the cranial base and vault dimensions in children. J Anthrop Soc Nippon 90:239-258.
23. Pirinen S, Majurin A, Lenko H-L, Koski K (1994). Craniofacial features in patients with deficient and excessive growth hormone. J Craniofac Genet Dev Biol 14:144-152.
24. Poole A, Greene I, Buschang P (1982). The effect of growth homone therapy on longitudinal growth of the oral facial structures in children. In: Factors and mechanisms influencing bone growth. Dixon A, Sarnat B, editors. New York: Alan R. Liss, Inc., pp. 499-516.
25. Ranly DM (1988). Biology of the supporting tissue. In: A synopsis of craniofacial growth. Norwalk, CT: Appleton and Lange, pp. 5-31.
26. Rongen-Westerlaken C, v.d. Born E, Prahl-Andersen B, von Teunenbroek A, Manesse P, Otten BJ, et al. (1993). Effect of growth hormone treatment on craniofacial growth in Turner's syndrome. ActaPaediatr 82:364-368.
27. SAS Institute Inc. (1992). SAS Technical Report P-229, SAS/STAT software: changes and enhancements. Release 06/07/1992. Cary, NC: SAS Institute Inc.
28. Spiegel RN, Sather AH, Hayles AB (1971). Cephalometric study of children with various endocrine diseases. Am J Orthod 59:362-375.
29. Stanhope R, Ackland F, Hamill G, Clayton J, Jones J, Preece MA (1989). Physiological growth hormone secretion and response to growth hormone treatment in children with short stature and intrauterine growth retardation. ActaPaediatr Scand 349(Suppl):47-52.
30. Stanhope R, Preece MA, Hamill G (1991). Does growth hormone treatment improve final height attainment of children with intrauterine growth retardation? Arch Dis Child 66:1180-1183.
31. Tanner JM, Whitehouse RH, Hughes PC, Vince FP (1971). Effect of human growth hormone treatment for one to seven years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome and other complaints. Arch Dis Child 46:745-782.